NOVEL ARYL-CYANOGUANIDINE COMPOUNDS

• Main Authors: STÖCKIGT, Detlef, WEISKE, Jörg, STRESEMANN, Carlo, BARACK, Naomi, STELLFELD, Timo, STEFANUTI, Ian, BRUMBY, Thomas, BADOCK, Volker, CHRIST, Clara, KÖHR, Silke, CRAMPTON, Rosemary Helen, TER LAAK, Antonius, MOWAT, Jeffrey Stuart, HILLIG, Roman
• Format: Patent
• Language: English; French; German
• Published: 18.10.2017
• Subjects: CHEMISTRY; HETEROCYCLIC COMPOUNDS; HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; METALLURGY; ORGANIC CHEMISTRY; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS

The present invention relates to protein-lysine N-methyltransferase SMYD2 (SET and MYND domain-containing protein 2) inhibitors, in particular SMYD2-inhibitory substituted cyanoguanidine-pyrazolines of general formula (I) wherein R1, R2, R3, R4, R5, X and r have the meaning as described and defined herein, as well as to pharmaceutical compositions comprising compounds according to the invention and to their prophylactic and therapeutic use for hyperproliferative disorders, in particular for cancer, respectively tumour disorders. The present invention furthermore relates to the use of SMYD2 inhibitors for benign hyperplasias, atherosclerotic disorders, sepsis, autoimmune disorders, vascular disorders, viral infections, neurodegenerative disorders, inflammatory disorders, atherosclerotic disorders and the control of male fertility.